The Impact Of Medical Corruption On World’s Economy

Authors

  • Qiuyu Xia

DOI:

https://doi.org/10.61173/pe4xt178

Keywords:

macroeconomic, Implications, Healthcare, Cost

Abstract

Corruption in the healthcare sector manifests in various forms, and its implications extend beyond compromised patient care. From a macroeconomic perspective, these illicit practices significantly burden economies by inflating healthcare costs, diverting crucial resources, and discouraging investments in the health sector. For patients, this can translate to exorbitant out-of-pocket expenses, decreased access to essential treatments, and even detrimental health outcomes. Moreover, from Transparency International’s 2016 resource, we can see that such practices undermine the principles of equity, universality, and quality that underpin health systems across the globe.

References

Kohler, G., et al. (2011). “Medicines and Corruption: A Risk Assessment.” Health Policy and Planning, 26(3), 160-172.

Transparency International. (2016). “Corruption in the Healthcare Sector.”

World Health Organization (WHO). (2010). “Corruption and health.”

Mackey, T. K., & Liang, B. A. (2012). “Pharmaceutical Digital Marketing and Governance: Illicit Actors and Challenges to Global Patient Safety and Public Health.” Globalization and Health, 8(1), 23.

Savedoff, W. D., & Hussmann, K. (2006). “Why are health systems prone to corruption?” Global Corruption Report 2006.

Gaitonde, R., et al. (2016). “Interventions to Reduce Corruption in the Health Sector.” The Cochrane Database of Systematic Reviews, 8.

Vian, T. (2008). “Review of Corruption in the Health Sector: Theory, Methods, and Interventions.” Health Policy and Planning, 23(2), 83-94.

Cohen, J. C., et al. (2019). “Anticorruption, Transparency and Accountability Measures in Health: A Cross-National Typology.” Social Science & Medicine, 232, 193-204.

Downloads

Published

2024-06-06